No headlines found.
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 8-Sep 8:00 AM ET)
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Globe Newswire (Mon, 27-Jul 8:00 AM ET)
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock trades on the NASDAQ stock market under the symbol FBIOP.
As of October 2, 2026, FBIOP stock price climbed to $16.86 with 25,185 million shares trading.
FBIOP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, FBIOP traded as high as $21.43 and as low as $4.72.
FBIOP has outperformed the market in the last year with a return of +131.9%, while the SPY ETF gained +16.1%. However, in the most recent history, FBIOP shares have underperformed the stock market with its stock returning -17.4% in the last 3 month period and -5.2% for the last 2 week period, while SPY has returned +3.6% and +1.0%, respectively.
FBIOP support price is $15.76 and resistance is $16.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBIOP shares will trade within this expected range on the day.
